Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies.
Author: González-Cantero, Álvaro; Teklu, Meron; Sorokin, Alexander V; Prussick, Ronald; González-Cantero, Jorge; Martin- Rodriguez, Jose Luis; Patel, Nidhi; Parel, Philip M; Manyak, Grigory A; Teague, Heather L; Rodante, Justin A; Keel, Andrew; Pérez-Hortet, Cristina; Sanchéz-Moya, Ana I; Jiménez, Natalia; Ballester, Asunción; Solis, Jorge; Fernandez-Friera, Leticia; Barderas, María G; Gonzalez-Calvin, Jorge L; Jaen, Pedro; Playford, Martin P; Dey, Amit K; Gelfand, Joel M; Mehta, Nehal N
Abstract: Psoriasis is associated with a higher risk of liver diseases. We investigated the impact of hepatic steatosis (European cohort) and hepatic inflammation (United States cohort) on subclinical atherosclerosis. In the European cohort (n = 76 psoriasis participants and 76 controls), nonalcoholic fatty liver disease, assessed by the sonographic hepatorenal index, was more prevalent in psoriasis than in controls (61% vs. 45%; P = 0.04). Participants with psoriasis with nonalcoholic fatty liver disease had a higher prevalence of subclinical atherosclerosis (ultrasonographic presence of plaque in femoral or carotid arteries) than participants with psoriasis without nonalcoholic fatty liver disease (61% vs. 23%; P = 0.006) and controls with nonalcoholic fatty liver disease (61% vs. 32%; P < 0.05). Sonographic hepatorenal index was a determinant of subclinical atherosclerosis in psoriasis (OR = 3.5; P = 0.01). In the United States cohort (n = 162 participants with psoriasis who underwent positron emission tomography and coronary computed tomography angiography), those with high hepatic 2-[fluorine-18]fluoro-2-deoxy-D-glucose uptake had higher noncalcified (1.3 [0.49 mm2] vs. 1.0 [0.40 mm2]), fibrofatty (0.23 [0.15 mm2] vs. 0.11 [0.087 mm2]), and lipid-rich necrotic core (4.3 [2.3 mm2] vs. 3.0 [1.7 mm2]) coronary burden (all P < 0.001). Hepatic 2-[fluorine-18]fluoro-2-deoxy-D-glucose uptake associated with noncalcified (β = 0.28; P < 0.001), fibrofatty (β = 0.49; P < 0.001), and lipid-rich necrotic core (β = 0.28; P = 0.003) burden. These results show the downstream cardiovascular effects of subclinical liver disease in psoriasis.
Universal identifier: http://hdl.handle.net/10641/2930
Files in this item
|2.-Subclinical Liver Disease is ...||722.6Kb||View/
- MEDICINA